Biolam
Entry
–
Hold
–
Exit
2022
Who owns Biolam?
Biolam is a Belgian Healthcare company, now owned by Management backed by investors, which acquired it in 2022 from Gimv.
Hand-verified · updated 2026-09-30
Open JSON · CC-BYOwnership history
1 ownership period · 1 lender on file
Exited
Last exited in 2022 to Management backed by investors.
Andera PartnersLender
2022 · present(4yr) · Acto Mezzanine IV · 2020 · Mezzanine
GimvExited 2022
exited 2022 · Gimv Portfolio
Secondary · to Management backed by investors
Gimv sold Biolam to Management backed by investors in 2022.
More from Gimv Portfolio
Other portfolio companies in the same fund.
More PE-backed in Healthcare
Comparable healthcare deals from other GPs.
Questions
Who owns Biolam?
Biolam is now owned by Management backed by investors, which acquired it in 2022 from Gimv.
When did Management backed by investors acquire Biolam?
Management backed by investors acquired Biolam in 2022, buying from Gimv.
Who did Biolam sell to?
Gimv sold Biolam to Management backed by investors in 2022 (Secondary).
Who has owned Biolam over time?
Biolam has been through 2 private-equity ownership periods: Andera Partners · via Acto Mezzanine IV · since 2022; Gimv · sold to Management backed by investors · (Secondary).
Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue